EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Serum alkaline phosphatase elevation as a preoperative sarcopenic biomarker in digestive cancer: a retrospective cohort study

Kohta Asano, Kae Tachibana, Satoru Shinoda, Takeshi Nakamura

Supportive Care in Cancer · 2025

DOI: 10.1007/s00520-025-09751-9 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Supportive Care in Cancer, 2025. Verfasst von Kohta Asano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan. uncle_harry.…. Hauptthemen laut MEDLINE: Sarcopenia, Alkaline Phosphatase, Digestive System Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Preoperative patients diagnosed with sarcopenia typically develop postsurgical complications and have an overall poor prognosis. Some studies have revealed an association of the sarcopenia development mechanism with inflammation; however, the mechanism of preoperative patients with cancer remains unknown. As previous studies have indicated elevated serum alkaline phosphatase (ALP) levels as a chronic inflammation biomarker, we focused on patients with digestive cancer as they experienced chronic inflammation and investigated whether it could be a preoperative sarcopenia marker. METHODS: The data from electronic medical records were investigated retrospectively. We included 274 patients diagnosed with digestive cancer at the Department of Gastroenterological Surgery of Yokohama City University Hospital and scheduled for surgery after perioperative sarcopenia screening at our rehabilitation outpatient clinic. We divided the patients into the sarcopenia (SC group; 58 patients) and nonsarcopenia (NSC group; 216 patients without sarcopenia) groups. RESULTS: The serum ALP level was significantly higher in the SC group (168.4 U/L vs. 100.4 U/L), when accounting for differences in confounders such as age, hepatic cancer, liver dysfunction, and bone fracture in the SC group, showing the correlation between ALP elevation and sarcopenia risk (p-value = 0.0018, odds ratio estimated at 1.0055; confidence interval: 1.0021-1.0090). Laboratory findings also showed clinically meaningful differences in albumin, ALP, and hemoglobin levels, neutrophil-to-lymphocyte ratio, and malnutrition parameters between the groups. CONCLUSION: Our findings suggest that serum ALP elevation induced by chronic inflammation is correlated with sarcopenia in preoperative patients with digestive cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaAlkaline PhosphataseDigestive System NeoplasmsHumansMaleFemaleRetrospective StudiesAgedMiddle AgedBiomarkersInflammationPreoperative PeriodCohort StudiesAged, 80 and overAdult

Stichwörter der Autor:innen

Alkaline phosphataseCancerInflammationPreoperative sarcopenia diagnosticsSarcopenia

Substanzen

Alkaline PhosphataseBiomarkers

Autor:innen und Institutionen

  • Department of Rehabilitation Medicine, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan. uncle_harry.7@outlook.com.
  • Department of Neuroanatomy, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan. uncle_harry.7@outlook.com.
  • Department of Rehabilitation Medicine, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
  • Department of Biostatistics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
  • Department of Rehabilitation Science, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.

Zitieren

APA

Asano, K., Tachibana, K., Shinoda, S., & Nakamura, T. (2025). Serum alkaline phosphatase elevation as a preoperative sarcopenic biomarker in digestive cancer: a retrospective cohort study. Supportive Care in Cancer. https://doi.org/10.1007/s00520-025-09751-9

Vancouver

Asano K, Tachibana K, Shinoda S, Nakamura T. Serum alkaline phosphatase elevation as a preoperative sarcopenic biomarker in digestive cancer: a retrospective cohort study. Supportive Care in Cancer. 2025. doi:10.1007/s00520-025-09751-9

BibTeX
@article{Asano2025,
  author = {Asano, Kohta and Tachibana, Kae and Shinoda, Satoru and Nakamura, Takeshi},
  title = {Serum alkaline phosphatase elevation as a preoperative sarcopenic biomarker in digestive cancer: a retrospective cohort study},
  journal = {Supportive Care in Cancer},
  year = {2025},
  doi = {10.1007/s00520-025-09751-9}
}
Kostenlos starten →